Bio
Tarik Massoud is a Professor of Neuroradiology and Molecular Imaging in the Department of Radiology, Stanford University School of Medicine, where he directs LEMNI (the Laboratory of Experimental and Molecular Neuroimaging), and is an attending diagnostic neuroradiologist in Stanford Health Care. He qualified from the Medical School of the Royal College of Surgeons in Ireland and then served as intern to two inspirational medical giants of their days, Dr. William H. (Willie) Bisset at the Royal Hospital for Sick Children in Edinburgh, UK, and Professor Sir Raymond (Bill) Hoffenberg, PRCP, at the Queen Elizabeth Hospital in Birmingham, UK. He trained in Radiology and Neuroradiology in Oxford, UCLA, and the University of Michigan, and is a Fellow of the Royal College of Radiologists. He has a research MD degree (NUI) in experimental neuroimaging (work conducted at UCLA), and a University of Cambridge PhD in molecular imaging (work conducted at the Crump Institute for Molecular Imaging at UCLA, and the Molecular Imaging Program at Stanford, Gambhir lab). He held Assistant and Associate Professorships of Radiology at UCLA, prior to a senior academic position in Neuroradiology at the University of Cambridge School of Clinical Medicine, UK.
He has published extensively and won numerous awards at scientific meetings. His work in experimental interventional neuroradiology is credited with the first development of morphologically-realistic pig models of bifurcation, terminal, and fusiform intracranial aneurysms (AJNR 1994, 1995); the carotid-jugular fistula-type pig AVM model using the rete mirabile (AJNR 1994, 1996, 2000; Neurosurgery 1998); intricate theoretical/computational hemodynamic models of brain AVMs (Neurosurgery 1996, Comput Biol Med 2019, Front Physiol 2019, J Neurointerv Surg 2022); and the concept of transvenous retrograde TRENSH treatment of brain AVMs (Neurosurgery 1999, 2013). His studies in reverse translational neuroimaging anatomy have led to new anatomical nomenclature in the nasal cavity (Clin Anat 2021), sacral foraminal conduits (Neuroradiology 2023), sacral posterior vertebral arch clefts and fenestrations (Radiology 2024), renaming of foramen of Monro as the interventricular canaliculus (Clin Anat 2020), and the first anatomical study of the caudolenticular gray bridges of the brain (Clin Anat 2023). His lab research in molecular imaging and therapy has led to engineering of the first split reporter molecular imaging system with potential for translation of protein-protein interaction imaging to human use using split HSV1-thymidine kinase and positron emission tomography (Nat Med 2010); and co-development of a nanoparticle-based intranasal Covid-19 vaccine for direct respiratory mucosal immunization (ACS Nano 2021). His papers have featured on the covers of 10 journals including FASEB Journal, Trends in Molecular Medicine, Science Translational Medicine, Molecular Cancer Therapeutics, Oncotarget, Clinical Anatomy, and Advanced Therapeutics.
From 2008 to 2023 he was founding Editor-in-Chief of the journal Reports in Medical Imaging, and is an editorial board member for numerous biomedical journals. He is the senior author or editor of 10 books, including "Glioblastoma: State-of-the-Art Clinical Neuroimaging", "Basilar Artery: A Clinical Review", "Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies", "Neuroimaging Anatomy: Parts 1 and 2", "What Radiology Residents Need to Know: Neuroradiology", and "The Subarachnoid Space: Percutaneous Access for Diagnosis and Image-Guided Therapies". In 2016 he was awarded a Special Faculty Permit ('eminent physician license') by the Medical Board of the state of California. In 2022, he was honored with a Lifetime Achievement Award by the Royal College of Surgeons in Ireland School of Medicine.
